Cancer Drug Parity Act of 2025

Hozzl · 2025-07-21T19:44:15Z

Explore the details of House Bill 4101 Cancer Drug Parity Act of 2025 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

7/21/2025, 7:44 PM

Summary of Bill HR 4101

The bill titled "To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider" was introduced in the 119th Congress on June 24, 2025.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 4101

Bill HR 4101 is currently in the status of Bill Introduced since June 24, 2025. Bill HR 4101 was introduced during Congress 119 and was introduced to the House on June 24, 2025. Bill HR 4101's most recent activity was Referred to the House Committee on Education and Workforce. as of June 24, 2025

Bipartisan Support of Bill HR 4101

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 4101

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 4101

To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider.